The global CRISPR Technology Market is estimated to be valued at US$ 2,251.2 Mn in 2023 and is expected to exhibit a CAGR of 19.2% over the forecast period 2022-2028, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
CRISPR technology is a revolutionary gene-editing tool that allows scientists to modify genes with precision and accuracy. It has gained significant attention in the healthcare and life sciences industry due to its potential in treating genetic disorders, developing novel therapies, and improving crop yields. The CRISPR technology offers several advantages such as cost-effectiveness, simplicity, and high efficiency, making it a preferred choice for researchers and companies working in the field of genetic engineering. The need for precise gene editing tools and the potential to revolutionize various industries are the key factors driving the demand for CRISPR technology in the global market.
Market Key Trends:
The key trend driving the growth of the CRISPR Technology Market is the increasing applications in gene editing. The ability of CRISPR technology to edit DNA with precision and accuracy has opened up new avenues for treating genetic diseases, developing personalized medicine, and enhancing crop productivity. The technology is being extensively used in clinical trials for gene therapy to cure diseases such as cancer, HIV, sickle cell anemia, and muscular dystrophy. Moreover, CRISPR technology is being employed in agriculture to develop genetically modified crops with improved yield, pest resistance, and nutritional value. The increasing demand for gene editing tools in various research fields and the potential to address unmet medical needs are expected to drive the market growth of CRISPR technology in the coming years.
PEST Analysis
Political: The political factors that can impact the CRISPR Technology Market include government regulations and policies regarding gene editing and genetic engineering. These regulations can affect the research and development activities in the market.
Economic: The economic factors influencing the market include the overall economic conditions of the countries where the market operates. Economic growth, inflation rates, and healthcare expenditure are some of the key economic factors that can affect the demand for CRISPR technology.
Social: Social factors such as the increasing awareness about genetic disorders and the potential of CRISPR technology to cure such diseases can drive the market growth. Additionally, ethical considerations regarding gene editing and its impact on society can also influence the market.
Technological: Technological advancements in gene editing techniques and CRISPR technology are key factors in the market growth. The development of more precise and efficient CRISPR systems, along with the availability of gene editing tools and kits, can impact the market positively.
Key Takeaways
The global CRISPR Technology Market is expected to witness high growth, exhibiting a CAGR of 19.2% over the forecast period (2022-2028). This growth can be attributed to various factors, including the increasing prevalence of genetic disorders and the potential of CRISPR technology to treat them effectively. The market is also driven by the growing investments in research and development activities for gene editing and advancements in CRISPR systems.
Regionally, North America is anticipated to be the fastest-growing and dominating region in the CRISPR Technology Market. This can be attributed to the presence of key market players, favorable government initiatives, and the availability of advanced healthcare infrastructure. The Asia Pacific region is also expected to witness significant growth due to increasing healthcare expenditure and rising awareness about genetic disorders.
Key players operating in the CRISPR Technology Market include Merck KGaA, Thermo Fisher Scientific, Origene Technologies, Inc., New England Biolabs, GenScript, GeneCopoeia, Inc., Cellecta, Inc., Agilent Technologies, Inc., PerkinElmer, Inc. (Horizon Discovery Ltd.), and Danaher Corporation (Integrated DNA Technologies). These companies are actively engaged in research and development activities, collaborations, and product launches to strengthen their market presence and gain a competitive edge.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.